LANGLEBIGE ALPHA-HÄMOLYSIN-NANOPOREN

Patent europeic · EP3478706 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3478706
Numer da la dumonda
EP17740304
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
28-06-2017
Publitgà
08-05-2019
Concedì
09-02-2022
La protecziun finescha il pli tard
27-06-2037
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C07K 14/31 (2006.01)
Prioritad
US 201662357230 P 30.06.2016
Dumonda PCT
PCT/EP2017/065972 28.06.2017
Publicaziun PCT
WO2018/002125 04.01.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. 01-07-2024

    Midada

    Published in Swissreg on 01.07.2024

  4. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  5. 21-12-2022

    Midada

    Published in Swissreg on 21.12.2022

  6. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  7. 09-02-2022

    Concedì

    Published in Swissreg on 09.02.2022

Partidas

Possessur

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventur

PORTER, Marshall

Petaluma California 94952, US

HARRIS, Corissa

Redwood City, CA 94063, US

DIPIETRO, Matthew

Gilroy California 95020, US

AMBROSO, Mark

San Diego California 92128, US

CRAIG, Timothy

0281 Oslo, NO

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.